Projects per year
Personal profile
Research Area Keywords
- Clinical Care
- Cancer
Fingerprint
Dive into the research topics where Candy Arentz is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
A RANDOMIZED PHASE III DOUBLE BLINDED PLACEBO CONTROLLED TRIAL OFASPIRIN AS ADJUVANT THERAPY FOR HER2 NEGATIVE BREAST CANCER: THE ABCTRIAL
Arentz, C. (PI), Abdelrahim, M. (CoI), Bernicker, E. H. (CoI), Chang, J. C. (CoI), Heyne, K. (CoI), Niravath, P. A. (CoI), Singh, M. (CoI) & Zhang, J. (CoI)
12/8/16 → 12/7/41
Project: Non Profit
-
A Randomized, Double-Blind, Phase III Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed by Adjuvant Continuation of Atezolizumab or Placebo
Niravath, P. A. (PI), Abdelrahim, M. (Key Personnel), Arentz, C. (Key Personnel), Heyne, K. (Key Personnel) & Singh, M. (Key Personnel)
Project: Clinical Trial
-
A Prospective Registry Study to Evaluate the Effect of the DCISionRT Test on Treatment Decisions in Patients With DCIS Following Breast Conserving Therapy
Templeton, S. (PI), Arentz, C. (Key Personnel), Chang, J. C. (Key Personnel), Darcourt, J. (Key Personnel), Dubrovsky, E. (Key Personnel), Haque, W. M. (Key Personnel), Heyne, K. (Key Personnel), Morgan, P. B. (Key Personnel), Niravath, P. A. (Key Personnel) & Singh, M. (Key Personnel)
Project: Clinical Trial
-
Multicenter Phase II Trial of Durvalumab (MEDI4736) With Trastuzumab and Pertuzumab Combination in HER2-Enriched and HER2-Amplified Breast Cancer (DTP Trial)
Niravath, P. A. (PI), Arentz, C. (Key Personnel), Guan, J. (Key Personnel), Mai, H. P. (Key Personnel), Puri, A. (Key Personnel) & Sun, K. (Key Personnel)
Project: Clinical Trial
Research output
- 9 Article
-
Utilization and Outcomes of the 21‐Gene Recurrence Score in pN2 Breast Cancer Patients
Haque, W., Verma, V., Mangalampalli, N., Schwartz, M. R., Butler, E. B., Sun, K., Jain, D., Arentz, C., Ramakrishnan, A. & Teh, B. S., Mar 2025, In: Anticancer Research. 45, 3, p. 1055-1061 7 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Postmastectomy radiation therapy following pathologic complete nodal response to neoadjuvant chemotherapy: A prelude to NSABP B-51?
Haque, W., Singh, A., Verma, V., Schwartz, M. R., Chevli, N., Hatch, S., Desai, M., Butler, E. B., Arentz, C., Farach, A. & Teh, B. S., Sep 2021, In: Radiotherapy and Oncology. 162, p. 52-59 8 p.Research output: Contribution to journal › Article › peer-review
8 Scopus citations -
Omission of radiation therapy following breast conservation in older (≥70 years) women with T1-2N0 triple-negative breast cancer
Haque, W. M., Verma, V., Hsiao, K. Y., Hatch, S., Arentz, C., Szeja, S., Schwartz, M., Niravath, P. A., Bonefas, E., Miltenburg, D., Butler, E. B. & Teh, B. S., Nov 1 2019, In: Breast Journal. 25, 6, p. 1126-1133 8 p.Research output: Contribution to journal › Article › peer-review
Open Access16 Scopus citations -
Addressing health disparities in Hispanic breast cancer: Accurate and inexpensive sequencing of BRCA1 and BRCA2
Dean, M., Boland, J., Yeager, M., Im, K. M., Garland, L., Rodriguez-Herrera, M., Perez, M., Mitchell, J., Roberson, D., Jones, K., Lee, H. J., Eggebeen, R., Sawitzke, J., Bass, S., Zhang, X., Robles, V., Hollis, C., Barajas, C., Rath, E. & Arentz, C. & 3 others, , 2015, In: GigaScience. 4, 1, 50.Research output: Contribution to journal › Article › peer-review
Open Access40 Scopus citations -
Breast hamartomas - Differential consideration in slow developing breast asymmetry
Cazorla, S. & Arentz, C., 2015, In: JPRAS Open. 3, 1, p. 17-21 5 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations